Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

Summary

GlobalData’s “Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015” report is an essential source of information and analysis on the global cardiac assist devices market. The report identifies the key trends shaping and driving the dynamism in the global cardiac assist devices market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global cardiac assist devices sector.

Scope

- Annualized global cardiac assist devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data for 2008.
- Analysis and review of the key events and milestones that will impact the future of the global cardiac assist devices market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the global cardiac assist devices market in the long run.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global cardiac assist devices market.
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global cardiac assist devices market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Support your go/non-go dilemma by identifying the markets that are least competitive and present significant opportunities for innovation and growth.
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

1 Table Of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015 9
2.1 Executive Summary 9
3 Cardiac Assist Devices:Role in Treating Heart Failure 10
3.1 Overview 10
3.1.1 Pathogenesis of Heart Failure 10
3.1.2 Role of Cardiac Assist Devices 10
3.2 Timeline 11
3.3 Market Segmentation 11
4 Global Cardiac Assist Devices Market 13
4.1 Cardiac Assist Devices Market Sizing 13
4.2 Cardiac Assist Devices Market Volume 15
4.3 Cardiac Assist Devices Country Comparison 16
4.3.1 US To Remain Key Region in the Future 17
4.3.2 Growth Opportunities Outside the US 18
4.4 Cardiac Assist Devices Market Dynamics 19
4.4.1 Market Drivers 19
4.4.1.1 Large patient population 19
4.4.1.2 Fulfilling the Unmet Need 19
4.4.1.3 Rising Prescription Rates due to Reduced Risks and Increasing Lifespan 19
4.4.2 Market Restraints 19
4.4.2.1 Long Development Time and Clinical Risks 19
4.4.2.2 Low Awareness and Availability in the Developing Economies 19
5 Competitive Landscape 20
5.1 Thoratec Corporation 20
5.1.1 Key Takeaway 20
5.2 Abiomed 21
5.2.1 Overview 21
5.2.1 Key Takeaway 21
5.3 SynCardia Systems, Inc 21
5.3.1 Overview 21
5.3.2 CardioWest temporary Total Artificial Heart – First Movers Advantage 22
5.3.3 Key Takeaway 22
5.4 Berlin Heart, Inc. 22
5.4.1 Overview 22
5.4.2 EXCOR - Leading Therapy Option in Children 22
5.4.3 Key Takeaway 23
6 Cardiac Assist Devices Pipeline Product Landscape 24
6.1 Overview 24
6.2 Cardiac Assist Devices Pipeline Product Analysis 26
6.2.1 Stage I: Meeting Patient Demand 27
6.2.2 Stage II: Effective Clinical Trial Information 27
6.2.3 Stage III: First Movers Advantage 27
6.3 Key Pipeline Product Description 28
6.3.1 AbioCor II 28
6.3.1.1 Product Status 28
6.3.1.2 Product Description 28
6.3.1.3 Product Patent Details 29
6.3.2 Cardiac Assist Devices Heartmate II (DT) 30
6.3.2.1 Product Status 30
6.3.2.2 Product Description 30
6.3.2.3 Heartmate II (DT) Clinical Trial 1 31
6.3.2.4 Heartmate II (DT) Clinical Trial 2 31
6.3.2.5 Heartmate II (DT) Clinical Trial 3 32
6.3.2.6 Heartmate II (DT) Clinical Trial 4 33
6.3.2.7 Product Patent Details 34
6.3.3 VentrAssist BTT 35
6.3.3.1 Product Status 35
6.3.3.2 Product Description 35
6.3.3.3 VentrAssist BTT Clinical Trial 1 36
6.3.3.4 VentrAssist BTT Clinical Trial 2 37
6.3.3.5 entrAssist BTT Clinical Trial 3 38
6.3.3.6 VentrAssist BTT Clinical Trial 4 39
6.3.3.7 VentrAssist BTT Clinical Trial 5 39
6.3.4 Pediatric M-Pump 39
6.3.4.1 Product Status 39
6.3.4.2 Product Description 40
7 New Entrants: Promising Products to Intensify Competition 41
7.1 Ventracor as an Acquisition Target 41
8 Pipeline Product Summary 42
9 Clinical Trial Summary 44
10 Appendix 48
10.1 Definitions 48
10.1.1 Cardiac Assist Devices 48
10.1.2 Intra-Aortic Balloon Pump Catheters 48
10.1.3 Total Artificial Heart 48
10.1.4 Ventricular Assist Devices 48
10.2 Company Information 49
10.2.1 Thoratec Corporation, Company Revenue 49
10.2.2 Thoratec Corporation, Key Events 50
10.2.2.1 Thoratec to Acquire HeartWare International 50
10.2.3 HeartMate II – Bridging the Gap between BTT and DT 50
10.2.4 Abiomed Inc., Company Revenues 51
10.2.5 Impella 2.5 Micro Heart Pump – Providing Competition to IABP 52
10.2.6 Key Strength: Only Total Artificial Heart On The Market 52
10.3 Research Methodology 53
10.4 Coverage 54
10.5 Secondary Research 54
10.6 Primary Research 55
10.7 Models 55
10.8 Forecasts 56
10.9 Expert Panels 56
10.10 GlobalData Consulting 56
10.11 Contact Us 57
10.12 Disclaimer 57